bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A J J M A M F J
2013: D N O S A

 
  Other news for:
Child
Migraine
 Resources from HONselect
Topamax Approval for Migraines Expanded to Younger Users
Adolescents ages 12-17 can now take the drug, FDA says

By Scott Roberts

MONDAY, March 31, 2014 (HealthDay News) -- U.S. Food and Drug Administration approval of the drug Topamax (topiramate) to prevent migraine headaches has been expanded to include adolescents 12 years to 17 years, the agency said Friday.

It's the first migraine-prevention drug approved for adolescents, the FDA said in a news release. Topamax was first sanctioned in 1996 to prevent seizures, and was approved to prevent migraines in adults in 2004.

Some 12 percent of the U.S. population has migraines, usually characterized by throbbing pain on one side of the head. Other symptoms may include nausea and sensitivity to light and sound.

Topamax was evaluated in clinical studies involving 103 adolescent migraine sufferers. The most common side effects included burning or prickling sensations in the extremities, upper respiratory infection, loss of appetite and abdominal pain.

The drug increases the risk of cleft lip and cleft palate birth defects among infants born to pregnant users, the FDA said. Doctors should carefully consider this risk before prescribing Topamax to females of childbearing age, the agency said.

Topamax is produced by Janssen Pharmaceuticals, based in Titusville, N.J.

More information

The FDA has more about this approval.

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=686299

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Pain
Risk
Infection
Adult
Cleft Lip
Seizures
Nausea
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact